Robert Arch
No más puestos en curso
Fortuna: - $ al 31/03/2024
Perfil
Robert H.
Arch served as President, CEO & Non-Independent Director at OncoSec Medical, Inc. from 2022 to 2023.
Prior to that, he was Head-Research at Elpiscience Biopharma Ltd.
from 2019 to 2021 and Head-Liver Disease Department at China Novartis Institutes for BioMedical Research Co., Ltd.
from 2017 to 2019.
Arch holds a doctorate degree from Julius-Maximilians-Universität Würzburg.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 21/03/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Antiguos cargos conocidos de Robert Arch.
| Empresas | Cargo | Fin |
|---|---|---|
| ONCOSEC MEDICAL INCORPORATED | Chief Executive Officer | 14/06/2023 |
Elpiscience Biopharma Ltd.
 Elpiscience Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Elpiscience Biopharma Ltd. engages in the development of cutting-edge immunotherapies to fight cancer. Its business scope includes technology research and development, transfer of own technology achievements and provision of related technical advice and technical services of biomedicine and biotechnology; import and export, and wholesale of mechanical equipment, electronic products, instrumentation, and plastic products. The company was founded on September 30, 2017 and is headquartered in Shanghai, China. | Chief Tech/Sci/R&D Officer | 01/06/2021 |
| China Novartis Institutes for BioMedical Research Co., Ltd. | Corporate Officer/Principal | 01/10/2019 |
Formación de Robert Arch.
| Julius-Maximilians-Universität Würzburg | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ONCOSEC MEDICAL INCORPORATED | Health Services |
| Empresas privadas | 2 |
|---|---|
Elpiscience Biopharma Ltd.
Elpiscience Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Elpiscience Biopharma Ltd. engages in the development of cutting-edge immunotherapies to fight cancer. Its business scope includes technology research and development, transfer of own technology achievements and provision of related technical advice and technical services of biomedicine and biotechnology; import and export, and wholesale of mechanical equipment, electronic products, instrumentation, and plastic products. The company was founded on September 30, 2017 and is headquartered in Shanghai, China. | Health Technology |
| China Novartis Institutes for BioMedical Research Co., Ltd. |
- Bolsa de valores
- Insiders
- Robert Arch
